INOVIO PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2018 to Q1 2024.
  • Inovio Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $178K, a 43.3% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.09M, a 13.3% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.22M, a 2.49% decline from 2022.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.25M, a 35.2% decline from 2021.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.94M, a 77.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.09M $178K -$136K -43.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.22M $282K -$31.2K -9.94% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $1.25M $313K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.25M $313K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.25M $313K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.25M $313K -$167K -34.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.42M $313K -$163K -34.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.58M $313K -$153K -32.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.74M $313K -$200K -38.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.94M $480K -$588K -55% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $2.52M $476K -$1.51M -76% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $4.03M $467K -$2.38M -83.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $6.41M $513K -$2.29M -81.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $8.7M $1.07M -$1.6M -60% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $10.3M $1.98M -$445K -18.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $10.7M $2.85M +$652K +29.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $10.1M $2.8M +$2.15M +327% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $7.95M $2.67M +$2.67M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $5.28M $2.43M +$2.43M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $2.85M $2.19M +$2.19M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $656K $656K +$656K Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.